Recently Featured

FDA Grants Early Approval for Cytokinetics’ Myqorzo, Marking a Milestone for the Biotech

January 26, 2026
The FDA has granted early approval for Cytokinetics’ aficamten, a significant milestone for the biotech firm as it marks its first U.S. nod since its inception in 1997. The agency’s decision comes ahead of the anticipated December 26 deadline and recognizes aficamten as a treatment for obstructive hypertrophic cardiomyopathy (oHCM), now branded as Myqorzo. This…

MHRA Emphasizes Simple Health Choices for Winter Wellness Amid Rising Cold Cases

January 25, 2026
As the cold weather approaches, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a reminder regarding the importance of simple health choices to enhance winter wellbeing. The agency’s guidance comes in response to the anticipated increase in coughs and colds typical of the season, underscoring the need for proactive health measures. This…

NIH Study on Topical Steroid Withdrawal Faces Setbacks Amid Federal Changes

January 25, 2026
On May 23, 2023, Kelly Barta arrived at the National Institutes of Health to address her long-standing health issues, having self-diagnosed topical steroid withdrawal (TSW) over a decade prior. As the president of a TSW advocacy group, Barta viewed the NIH’s interest in researching this controversial condition as a significant advancement, given the skepticism surrounding…

Federal Cuts Threaten U.S. Food Safety Amid Rising Health Risks

January 25, 2026
The recent infant botulism outbreak linked to ByHeart formula, which affected dozens of infants, underscores the fragility of the U.S. food safety system and highlights the critical need for effective regulatory oversight. This incident serves as a stark reminder of the potential consequences of lapses in food safety protocols, emphasizing the importance of a responsive…

Ongoing Cases